William Beaumont Hospital-Ophthalmology Research
				
				Royal Oak, Michigan 48073
We've found
        1 trials
        at this facility
      	
	Macular Degeneration Clinical Trial
	
Updated: 1/7/2016
  
  
  Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 1/7/2016
Click here to add this to my saved trials
	    
	